Amgen has rallied about 27% to 58.50, since its lows in March. As sales of denosumab start to climb, the stock could command a higher multiple -- and, eventually, a price of 78.

Investors for the long term should look at M&T, with its consistent earnings growth and deft hand at managing small-business clients. The stock could see at least 30% upside.

EOG shares could rally into the 80s from around 70 as the company tilts its production mix towards oil. A pristine balance sheet helps, too.

If the economy continues improving by bits and pieces, the September-quarter earnings of S&P 500 stocks may end up better than the sequentially flat forecast of analysts surveyed by Thomson Reuters. But with the market already up by half since its March nadir, is there a stock play for the investor who wants to bet on better-than-expected third-quarter earnings? One such idea occurred to JPMorgan equity strategist Thomas J. Lee while he was reading the short-interest tables in his favorite weekly stock-market tabloid (yours, too, we trust). Lee suggests buying the shares of some large businesses that are heavily shorted. Among those names: Citigroup (C), Bank of America (BAC), EMC (EMC), and Las Vegas Sands (LVS).

If the economy continues improving by bits and pieces, the September-quarter earnings of S&P 500 stocks may end up better than the sequentially flat forecast of analysts surveyed by Thomson Reuters. But with the market already up by half since its March nadir, is there a stock play for the investor who wants to bet on better-than-expected third-quarter earnings? One such idea occurred to JPMorgan equity strategist Thomas J. Lee while he was reading the short-interest tables in his favorite weekly stock-market tabloid (yours, too, we trust). Lee suggests buying the shares of some large businesses that are heavily shorted. Among those names: Citigroup (C), Bank of America (BAC), EMC (EMC), and Las Vegas Sands (LVS).

If the economy continues improving by bits and pieces, the September-quarter earnings of S&P 500 stocks may end up better than the sequentially flat forecast of analysts surveyed by Thomson Reuters. But with the market already up by half since its March nadir, is there a stock play for the investor who wants to bet on better-than-expected third-quarter earnings? One such idea occurred to JPMorgan equity strategist Thomas J. Lee while he was reading the short-interest tables in his favorite weekly stock-market tabloid (yours, too, we trust). Lee suggests buying the shares of some large businesses that are heavily shorted. Among those names: Citigroup (C), Bank of America (BAC), EMC (EMC), and Las Vegas Sands (LVS).

If the economy continues improving by bits and pieces, the September-quarter earnings of S&P 500 stocks may end up better than the sequentially flat forecast of analysts surveyed by Thomson Reuters. But with the market already up by half since its March nadir, is there a stock play for the investor who wants to bet on better-than-expected third-quarter earnings? One such idea occurred to JPMorgan equity strategist Thomas J. Lee while he was reading the short-interest tables in his favorite weekly stock-market tabloid (yours, too, we trust). Lee suggests buying the shares of some large businesses that are heavily shorted. Among those names: Citigroup (C), Bank of America (BAC), EMC (EMC), and Las Vegas Sands (LVS).

Among the big, crowded shorts, the strategist suggested a bet on those that his firm's analysts rate Overweight. Those are the four names listed above. Additionally, he suggests buying three that JPMorgan rates Neutral: Sprint Nextel (S), General Electric (GE) and the American depositary shares of the Brazilian metals producer Vale (VALE).